Skip to main content

Table 3 Immunoassays of blood Insulin, HOMA-IR, Cortisol and Testosterone (in men) in people with treated T2D before (baseline) and after treatment (24-week) within Main (Experimental) and Control (Conventional) groups (M ± SEM)

From: Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial

Variables

Main group, n = 208

Control group, n = 64

Baseline

24-week

Baseline

24-week

Immunoassay insulin (nU/L)

23.2 ± 1.0

6.5 ± 0.3*

20.9 ± 1.2

15.0 ± 1.2*

Immunoassay cortisol (nmol/L)

751.2 ± 6.7

445.7 ± 5.3*

747.2 ± 8.9

739.5 ± 9.1

HOMA-IR index

8.9 ± 0.44

1.30 ± 0.29*

7.97 ± 0.53

4.03 ± 0.55*

Variable in men

 

Main group, n = 99

Control group, n = 30

Blood testosterone (ng/dL)

365.9 ± 13.8

885.2 ± 21.2*

379.2 ± 19.6

395.2 ± 24.5

  1. Abbreviations: ANADET analimentary detoxication, HOMA-IR Homeostasis Model Assessment insulin resistance index, IR insulin resistance, M mean, SEM standard error of the mean, T2D type 2 diabetes
  2. *P < 0.0001 were set as significant between baseline and 24-week treatment within group comparison